In addition, the catalytic subunit brahma related gene 1 (BRG1) of the SWI/SNF complex can maintain the stemness of glioma‐initiating cells by inhibiting the STAT3/TXNIP pathway, resulting in the resistance of glioma‐initiating cells to the chemotherapeutic drugs temozolomide (TMZ) and carmustine.60 The gene discussed is TXNIP; the disease is central nervous system cancer.